Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Cerecor Shares Rise 13% on Sale of Pediatric Portfolio for $32 Million

Shares of Cerecor Inc. are trading higher today after reporting that it will sell its pediatric portfolio to Aytu BioScience for $32 million in a combination cash and stock deal. Biopharmaceutical company Cerecor Inc. (CERC:NASDAQ) , which focuses on development and ...

Buzz on the Bullboards: Holiday blues, or blue-chips?

Are you expecting a relaxed market heading into the holidays? That will hardly be the case. Savvy investors and brokers know this is the time to shine. With every twist and turn the global economy has been throwing our way, the right move is keeping active. Th...

This Economic Indicator Is Proving the Naysayers Wrong

\ Flying in the face of negative economic news, U.S. factories picked up steam for the third straight month in November. The preliminary manufacturing purchasing manager’s index (PMI), a leading indicator we closely track here at U.S. Global Investors, p...

Maple Gold for $3.02 an Ounce US

I have been pounding the table for months believing we would have a general stock market high in September leading into a giant crash starting in October. And I believed there would be a liquidity event that would blast hell out of the "Everything Bubble." It's here. ...

Cassava Sciences' Shares Trade Up 20% on Updated Phase 2a Alzheimer's Data

Shares of Cassava Sciences traded 20% higher after the firm presented additional data from the Phase 2a study of its investigational drug candidate PTI-125 for Alzheimer's disease to the Clinical Trials on Alzheimer's Disease conference in San Diego, Calif. Neurodegen...

$7.5 Million Debt Conversion Clears Path for Major Upside

Hot on the heels of Torchlight Energy Resources discovering a new oil field in Texas, debt holders have elected to convert to Working Interest. Torchlight Orogrande drilling Torchlight Energy Resources Inc. (TRCH:NASDAQ) , a dynamic junior oi...

Weakness Appears To Be Setting For This Weeks Economic Data

As the world reacts to the global economic slowdown because of the COVID-19 virus event and the massive stimulus programs and central bank efforts to support the global economy, investors still expect weakness in the US and foreign markets. We believe this expected weakness ...

Cassava Shares Rise on Updated Phase 2b Alzheimer's Drug Trial Data

Shares of Cassava Sciences traded 70% higher after the firm provided updates from its Phase 2b study of PTI-125 for use in treating Alzheimer' disease. Clinical-stage biotechnology company Cassava Sciences Inc. (SAVA:NASDAQ) , which focuses on neurodegenerative di...

BMW, BYD, Daimler, Tesla, Volkswagen: Battery cars threaten a forced shutdown

Electric mobility is one of the hottest topics of our time. Politicians have prioritized the change in road traffic in connection with climate change. Ever stricter emission limits are intended to encourage manufacturers and users to buy battery and hybrid cars. Because drivin...

Buzz on the Bullboards: ‘Till debt do us party

These last few weeks markets across the globe have been swaying up and down. Looking at media headlines, are we about to see a full recovery of the global economy … or is more trouble ahead? Data showed that consumer inflation unexpectedly accelerated in April, th...
1 2 3 4 5